Introduction
The National Kidney Foundation Dialysis Outcomes Quality Improvement (NFK-KDOQI) [1] suggests that primary angioaccess remains the best type of access for haemodialysis. Angioaccesses have the advantage of good patency rates, lower complication risks and lower morbidity compared to central venous catheters [2] . In addition, central venous catheters inserted for dialysis are associated with an increased risk of thrombosis, infection, risk of central stenosis and shorter life expectancy when compared to other types of access [3] .
NFK-KDOQI recommends that primary angioaccess should be constructed in 50% of all new patients electing to have haemodialysis and that 40% should have autogenous angioaccess (radiocephalic or brachiocephalic). However, if an autogenous option is not possible then an arteriovenous graft of synthetic material or transposed brachial or basilic vein should be considered. In the US, campaigns have been launched to attain a pre-emptive angioaccess rate of 66% nationwide by 2009 [4, 5] .
The population in the UK is ageing with 19% aged !65 years and the oldest age group (!80) being the fastest growing sector and accounting for 5% of the total population [6] . There has been an increase in the number of elderly patients diagnosed with Stage 5 chronic kidney disease (CKD) requiring haemodialysis with subsequent improved survival rates [7] . There is still a debate about guidelines for angioaccess formation. A recent study [8] investigating access-related survival and morbidity for dialysis catheters and angioaccess has evaluated angioaccess non-use rate in an elderly population and has shown an 80% 1-year patency rate in the older group (>70 years old) with a non-use rate of only 16%.
Is the elderly population approaching end-stage renal disease (ESRD) population suitable for native angioaccess formation? This remains a valid question that we are trying to answer in the study we are reporting here.
Patient and methods
All patients included have had a pre-emptive arteriovenous access created between January 2006 and December 2007 in our network. The patients were divided into three age groups including controls (<70 years) Group A, young old (70-79) Group B and old (!80 years) Group C. Groups A, B and C included 110 (45%), 82 (34%) and 51 (21%) patients, respectively.
Patients who had a previous angioaccess created but remained dialysis independent were included. Patients who have had previous haemodialysis via an angioaccess or a venous catheter were excluded. Any patients with a failing transplant or peritoneal dialysis and who have had a planned angioaccess creation prior to commencing haemodialysis were excluded as the vast majority of these cases were already previously dialysed. In addition, any patients transferring modality were excluded. Age, type of access, whether the fistula was used or not and access failure date and cause were collated.
The primary aim of our study was to assess if age influences successful first dialysis when a pre-emptive angioaccess was created. The secondary aim was to investigate what risk factors could be associated with angioaccess failure and to establish primary failure and primary, primary assisted and secondary patency rates. Primary patency was defined as the interval between angioaccess formation and the first intervention for failure. Primary assisted patency was defined as patent access in which any intervention had been performed to prevent impending failure. Secondary patency was the interval between access placement and abandonment.
Data were expressed as mean AE SD. Differences in variables between groups were compared using Student's t-test and chi-square test. KaplanMeier curves and log-rank test were used to describe and compare access patency. Actuarial patient survival was calculated using life table survival testing. Comorbidity score was calculated using the Davies score. Significant differences were defined as P 0.05. A Cox regression analysis was used to measure the effect of comorbidities on the primary patency rate. Software Package for Social Sciences (SPSS-version 17.0 for Windows; SPSS Inc., Chicago, IL) was used for statistical analysis.
Results
Out of 243 patients who had a pre-emptive angioaccess during the time frame of the study, there were 129 males (53%) and 114 females (47) ( Table 1) .
In Group A, the main causes for renal failure were diabetes (27.2%), glomerulonephritis (24.5%) and polycystic kidney disease (9.1%). In Groups B and C, the main causes were diabetes (24.4 and 13.7%), glomerulonephritis (29.3 and 37.3%) and hypertension (12.2 and 19.6%). The estimated Glomerular Filtration Rate (eGFR) at the time of creation was 12 AE 2.9 (5-19), 13 AE 4 (5-23), 12 AE 3.1 (9-15) mL/min for Groups A, B and C, respectively.
Classifying patients according to Davies comorbidity score showed that the majority of all groups had a Davis score of 1 with higher numbers scoring 0 in Group A when compared to Groups B and C (P < 0.5). In Groups B and C, more patients scored 3 than in Group A (P < 0.05) Two hundred and thirty native accesses were created, whereas only 13 grafts were inserted (only, if the patients were within 8 weeks from commencing haemodialysis). Radiocephalic (RC) or brachiocephalic (BC) angioaccesses were carried out in 202 cases (97 and 105, respectively), basilic vein transposition in 23 and ulnobasilic access in 5 ( Table  2 ). Bypasses were either brachioaxillary or axilloaxillary straight 6-40 PTFE intering grafts (Gore TexÒ, Flagstaff, AZ).
Preoperative imaging (i.e. duplex scan) was only requested when clinical examinations were inconclusive regardless of the diabetes status; 71 scans were requested. Duplex scan were requested for 42, 17.1 and 21.6% of the patients in Groups A, B and C, respectively.
The percentage of patients receiving their first dialysis through (pre-emptively created) angioaccess was 58, 47.5 and 65% in Groups A, B and C, respectively (P > 0.05). The mean time from angioaccess creation to first dialysis was 5.9 AE 4.4 (0.5-20.9), 10.8 AE 9.6 (1.3-32.1) and 8.0 AE 6.4 (0.9-16.2) months for Groups A, B and C, respectively. However, when excluding patients not needing dialysis immediately and those who had subsequently a successful transplant, results showed 88, 71 and 87% (P > 0.05).
There were a total of 15 (6.17%) deaths in all groups. Six (2.46%) occurred prior to starting dialysis, four in Group B and two Group C (P > 0.05). Nine died after starting dialysis, three (3%) in Group A, five (6%) in B and one (2%) in C (P > 0.05) ( Table 3 ). The 1-year actuarial patient survival rate was 95.5, 92.7 and 94.1% for Groups A, B and C, respectively.
Access complications included clotting in 27 (24.5%), 22 (26.8%) and 12 (23.5%) patients (P > 0.05) and stenosis in 13 (11.8%), 12 (14.6%) and 12 (23.5%) patients (P > 0.05) in Groups A, B and C, respectively. Post-operative primary non-function of the angioaccess was diagnosed in three (2.7%), two (2.4%) and two (3.9%) patients in Groups A, B and C, respectively. Access superficializations were required in 5.5, 2.4 and 2.0% in Groups A, B and C, respectively (P > 0.05). When patients required dialysis through a central venous catheter despite prior access formation, the most common cause was access thrombosis in 4.5, 8.5 and 1.9% in Groups A, B and C, respectively (P > 0.05). Other causes included rapidly worsening renal function before access maturation in 0.9, 1.2, and 0% or failure to mature in 0, 1.2, 1.9%, respectively. Two accesses were ligated because of rupture and bleeding in Groups A and B. Steal syndrome was diagnosed in four BC in Groups A and B (two each). All accesses were successfully rescued by distalization of the anastomosis.
The patency rates are illustrated in Figures 1-3 . The primary patency rates after 12 months were 68, 62 and 58% for Groups A, B and C, respectively (P > 0.05), however, the overall primary patency rate was significantly lower in Group B when compared with Groups A and C: 23 versus 40% and 42%, respectively (P < 0.05) at a median follow-up of 24.3, 21.2 and 19.1 months, respectively. The assisted primary patency rate after 12 months was 68, 73, 69% for Groups A, B and C, respectively, (P > 0.05) and 35, 33 and 49% overall, respectively, (P > 0.05) at a median follow-up of 26.2, 21.6 and 23.3 months, respectively. By comparison, secondary patency rates after 12 months were 78, 77 and 79%, respectively (P > 0.05). Overall, secondary patency was 42, 45 and 42%, respectively, (P > 0.05) at a median follow-up of 32, 30.5 and 23.5 months, respectively.
There was no significant correlation between age, gender, Davies comorbidity scores, diabetes and eGFR and the primary patency rates within each group and the whole study population using Cox regression survival analysis (P > 0.05).
Discussion
This study shows that any patient, regardless of their age, should be considered for pre-emptive angioaccess for haemodialysis. The timely placement of vascular access for dialysis is essential to reduce morbidity and mortality among the dialysis population. The pathway taken by many patients often includes venous catheter insertion, then arteriovenous fistula placement, especially for those that had to start dialysis unplanned as 'crash-landers' [9] . Patency rates are significantly higher for fistulae created pre-emptively and are also much more cost effective than catheters, which are associated with higher morbidity and mortality rates than pre-emptive fistulae [10] [11] [12] .
The Fistula First initiative [4] in the USA has identified a potential savings of $840 million over a lifetime of the entire US dialysis population if the target of 66% of preemptively created fistulae was met [13] . They also have identified economic barriers and disincentives to providing adequate pre-dialysis care, surgical procedures and access flow monitoring.
The elderly population is increasing in the UK. Debates regarding whether they should or not have dialysis continues.
One study comparing the outcome of dialysis versus conservative management in a population aged >75 has shown that 1-year survival rates were 84 and 68% in the dialysis and conservative management groups, respectively [14] . However, the better survival advantage was lost for patients presenting with multiple comorbidities in the dialysis group.
Several studies have demonstrated that the cost of renal replacement therapy for the elderly was not significantly higher [15] .
It is therefore possible to speculate that when patients with ESRD survive beyond the age of 75, there has been some natural selection that has allowed only the 'fittest' to remain. This advocates a proactive policy for pre-emptive vascular access provision that that is medically sound and beneficial financially.
A recent meta-analysis reported that RC fistulas had a higher primary failure rate than BC in a dialysis population aged >80 [16] . It was therefore proposed that elbow rather than distal angioaccesses should be preferred in that population. It is worth considering, as it seems extremely unlikely that these patients would run out of native access options just because a proximal fistula had been favoured over a distal. This meta-analysis had focused on a population already on dialysis where central venous catheters had to be used in order to allow access maturation. In our pre-emptive population, if created well in advance by dedicated access surgeons, there is enough time to try a distal option first even with a slightly higher risk of failure as long as there is no need for central venous catheters. In another study [17] examining failure and patency rates of distal and brachial angioccesses, it was shown that age did not predict a worse outcome for distal fistulae. Richardson et al. [18] , however, concluded that autogenous fistulas may not be the best option for patients >70 years old because of low patency rates and a higher mortality. With the same concerns, it has been recommended that vascular access formation guidelines be modified for elderly patients [19] . In our study, the 1-year actuarial survival rate was 92% in Group C and was not different from either Group A or B. Also, there was no significant correlation between age, comorbidities and primary patency rates.
This study was meant to help us overhaul our practice and decide whether it was clinically sound, ethically acceptable and financially viable to operate pre-emptively on an elderly pre-dialysis population. One of the arguments was that even if our procedures had a very low primary failure rate, the total number of older patients that would start dialysis would be small because of other comorbidities and a shorter life expectancy than younger patients with CKD. None of these assumptions have been established. Only six deaths occurred in patients still in CKD, the number of patients successfully dialysed for the first time through their access was very high, our patency rates compared favourably with what is generally observed in the literature and our complication rates have been comparable and within expected outcome in our three groups.
This study clearly shows that it might be reasonable to consider any patient with CKD for pre-emptive angioaccess formation regardless of their age, but on a case-by-case basis and with an emphasis on comorbidities.
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